Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27
Zepbound ( Tirzepatide ) Zepbound is a newer medication that combines both GLP-1 and GIP receptor agonist actions, impacting not only appetite but also other metabolic pathways
For patients seeking guidance, the AASM notes that sleep physicians and experts at AASM-accredited sleep centers can help patients who have sleep apnea determine if Zepbound is appropriate for them
The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts
While cost and insurance confusion often deter patients, Klinic removes these barriers by verifying your benefits and handling all prior authorizations
US$ 24.30
-(1).png?sfvrsn=c236e848_3)
US$ 27.41
US$ 21.02
US$ 24.70
US$ 26.12
